fig3

Opportunities and challenges of implementing Pharmacogenomics in cancer drug development

Figure 3. Possibilities of PGx implementation in each R&D phase

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/